[1] Rao Q, Zheng G G, Li G, et al. Membrane-bound macrophage colony-stimulating factor mediated autojuxta
-crine downregulates matrix metalloproteinase-9 release on J6-1 leukemic cell[J]. Exp Biol Med (Maywood),
2004, 229(9): 946-953
[2] Ławicki S, Szmitkowski M, Wojtukiewicz M. The pretreatment plasma level and diagnostic utility of M-CSF
in benign breast tumor and breast cancer patients[J]. Clin Chim Acta, 2006, 371(1-2): 112-116
[3] Uemura Y, Kobayashi M, Nakata H, et al. Effects of GM-CSF and M-CSF on tumor progression of lung
cancer: roles of MEK1/ERK and AKT/PKB pathways[J]. Int J Mol Med, 2006, 18(2): 365-373
[4] Li G, Song Y H, Wu K F, et al. Clone and expression of mutant M-CSF and its receptor from human leukemic cell line J6-1[J]. Leuk Res, 2002, 26 (4): 377-382
[5] Cao Zhen-Yu, Wu Ke-Fu, Song Yu-Hua, et al. M-CSF targeting into LCL nucleus behaves as a malignancy
promotor[J]. Chin J Cancer Res, 2003, 15 (4): 262-268
[6] Wang Y, Zeigler M M, Lam G K, et al. The role of the NADPH oxidase complex, p38 MAPK, and Akt in
regulating human monocyte/macrophage survival[J]. Am J Respir Cell Mol Biol, 2007, 36 (1): 68-77
[7] Kirma N, Luthra R, Jones J, et al. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor
c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation[J]. Cancer Res, 2004, 64(12): 4162-4170